It's an upgrade worth making, but it comes down to your privacy concerns.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

OpenAI and Broadcom unveiled Jalapeño, a custom AI inference chip designed in nine months. Early tests show 50% cost savings over standard GPUs, with deployment planned for late 2026.

While the US imagines AI through dystopia and lost human agency, China’s embrace of the technology is shaped by memories of poverty, national humiliation and the conviction that technological progress ...

Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...